Skip to main content

Advertisement

SpringerLink
Log in

The central role of the pathologist in the management of patients with cervical cancer: ESGO/ESTRO/ESP guidelines

  • Review and Perspectives
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

The European Society of Gynaecological Oncology (ESGO), the European Society for Radiotherapy & Oncology (ESTRO) and the European Society of Pathology (ESP) nominated an international multidisciplinary development group consisting of practicing clinicians who have demonstrated leadership and expertise in cervical cancer to produce evidence-based guidelines regarding all aspects of the management of patients with this disease. Herein, we provide a detailed analysis of the pathological reporting of cervical carcinoma specimens, focusing on practical aspects of specimen sampling and on the core pathological data which are critical for patient management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Cibula D, Poetter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, Köhler C, Landoni F, Lax SF, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer. Virchows Arch. 2018 May 4. https://doi.org/10.1007/s00428-018-2362-9

  2. Cibula D, Poetter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, Köhler C, Landoni F, Lax SF, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer. Radiother Oncol. 2018 Apr 12. pii: S0167-8140(18)30135-X. https://doi.org/10.1016/j.radonc.2018.03.003

  3. Cibula D, Poetter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, Köhler C, Landoni F, Lax SF, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer. Int J Gynecol Cancer. 2018 May;28(4):641–655. https://doi.org/10.1097/IGC.0000000000001216

  4. McCluggage WG, Judge MJ, Alvarado-Cabrero I, Duggan MA, Horn LC, Hui P, Ordi J, Otis CN, Park KJ, Plante M, Stewart CJR, Wiredu EK, Rous B, Hirschowitz L (2017) Data set for the reporting of carcinomas of the cervix: recommendations from the international collaboration on Cancer reporting (ICCR). Int J Gynecol Pathol 37:205–228. https://doi.org/10.1097/PGP.0000000000000412

    Article  Google Scholar 

  5. Kurman RJ, Carcangiu ML, Herrington S, Young RH (eds) (2014) Tumours of the female reproductive organs. IARC Press, Lyon

    Google Scholar 

  6. Talia KL, Stewart CJR, Howitt BE, Nucci MR, McCluggage WG (2017) HPV-negative gastric type adenocarcinoma in situ of the cervix: a Spectrum of rare lesions exhibiting gastric and intestinal differentiation. Am J Surg Pathol 41(8):1023–1033. https://doi.org/10.1097/PAS.0000000000000855

    Article  PubMed  Google Scholar 

  7. Karamurzin YS, Kiyokawa T, Parkash V, Jotwani AR, Patel P, Pike MC, Soslow RA, Park KJ (2015) Gastric-type endocervical adenocarcinoma: an aggressive tumor with unusual metastatic patterns and poor prognosis. Am J Surg Pathol 39(11):1449–1457. https://doi.org/10.1097/PAS.0000000000000532

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kenny SL, McBride HA, Jamison J, McCluggage WG (2012) Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-beta. Am J Surg Pathol 36(6):799–807. https://doi.org/10.1097/PAS.0b013e31824a72c6

    Article  PubMed  Google Scholar 

  9. Howitt BE, Kelly P, McCluggage WG (2017) Pathology of neuroendocrine tumours of the female genital tract. Curr Oncol Rep 19(9):59. https://doi.org/10.1007/s11912-017-0617-2

    Article  PubMed  Google Scholar 

  10. Benda JA (1996) Histopathologic prognostic factors in early stage cervical carcinoma. J Natl Cancer Inst Monogr 21:27–34

    Google Scholar 

  11. Tiltman AJ (2005) The pathology of cervical tumours. Best Pract Res Clin Obstet Gynaecol 19(4):485–500. https://doi.org/10.1016/j.bpobgyn.2005.02.003

    Article  PubMed  CAS  Google Scholar 

  12. Zaino RJ, Ward S, Delgado G, Bundy B, Gore H, Fetter G, Ganjei P, Frauenhoffer E (1992) Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A gynecologic oncology group study. Cancer 69(7):1750–1758

    Article  PubMed  CAS  Google Scholar 

  13. Diaz De Vivar A, Roma AA, Park KJ, Alvarado-Cabrero I, Rasty G, Chanona-Vilchis JG, Mikami Y, Hong SR, Arville B, Teramoto N, Ali-Fehmi R, Rutgers JK, Tabassum F, Barbuto D, Aguilera-Barrantes I, Shaye-Brown A, Daya D, Silva EG (2013) Invasive endocervical adenocarcinoma: proposal for a new pattern-based classification system with significant clinical implications: a multi-institutional study. Int J Gynecol Pathol 32(6):592–601. https://doi.org/10.1097/PGP.0b013e31829952c6

    Article  PubMed  Google Scholar 

  14. Roma AA, Diaz De Vivar A, Park KJ, Alvarado-Cabrero I, Rasty G, Chanona-Vilchis JG, Mikami Y, Hong SR, Teramoto N, Ali-Fehmi R, Rutgers JK, Barbuto D, Silva EG (2015) Invasive endocervical adenocarcinoma: a new pattern-based classification system with important clinical significance. Am J Surg Pathol 39(5):667–672. https://doi.org/10.1097/PAS.0000000000000402

    Article  PubMed  Google Scholar 

  15. Roma AA, Mistretta TA, Diaz De Vivar A, Park KJ, Alvarado-Cabrero I, Rasty G, Chanona-Vilchis JG, Mikami Y, Hong SR, Teramoto N, Ali-Fehmi R, Barbuto D, Rutgers JK, Silva EG (2016) New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome. Gynecol Oncol 141(1):36–42. https://doi.org/10.1016/j.ygyno.2016.02.028

    Article  PubMed  PubMed Central  Google Scholar 

  16. Roma AA, Park KJ, Xie H, De Vivar AD, Alvarado-Cabrero I, Rutgers JKL, Barbuto D, Silva EG (2017) Role of lymphovascular invasion in pattern C invasive Endocervical adenocarcinoma. Am J Surg Pathol 41(9):1205–1211. https://doi.org/10.1097/PAS.0000000000000822

    Article  PubMed  Google Scholar 

  17. Rutgers JK, Roma AA, Park KJ, Zaino RJ, Johnson A, Alvarado I, Daya D, Rasty G, Longacre TA, Ronnett BM, Silva EG (2016) Pattern classification of endocervical adenocarcinoma: reproducibility and review of criteria. Mod Pathol 29(9):1083–1094. https://doi.org/10.1038/modpathol.2016.94

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Day E, Duffy S, Bryson G, Syed S, Shanbhag S, Burton K, Lindsay R, Siddiqui N, Millan D (2016) Multifocal FIGO stage IA1 squamous carcinoma of the cervix: criteria for identification, staging, and its good clinical outcome. Int J Gynecol Pathol 35(5):467–474. https://doi.org/10.1097/PGP.0000000000000269

    Article  PubMed  CAS  Google Scholar 

  19. McIlwaine P, Nagar H, McCluggage WG (2014) Multifocal FIGO stage 1A1 cervical squamous carcinomas have an extremely good prognosis equivalent to unifocal lesions. Int J Gynecol Pathol 33(3):213–217. https://doi.org/10.1097/PGP.0b013e31829040ce

    Article  PubMed  Google Scholar 

  20. Delgado G, Bundy BN, Fowler WC Jr, Stehman FB, Sevin B, Creasman WT, Major F, DiSaia P, Zaino R (1989) A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol 35(3):314–320

    Article  PubMed  CAS  Google Scholar 

  21. Pol FJ, Zusterzeel PL, van Ham MA, Kuijpers DA, Bulten J, Massuger LF (2015) Satellite lymphovascular space invasion: an independent risk factor in early stage cervical cancer. Gynecol Oncol 138(3):579–584. https://doi.org/10.1016/j.ygyno.2015.06.035

    Article  PubMed  Google Scholar 

  22. Boyle DP, McCluggage WG (2015) Stratified mucin-producing intraepithelial lesion (SMILE): report of a case series with associated pathological findings. Histopathology 66(5):658–663

    Article  PubMed  Google Scholar 

  23. de Boer M, van Dijck JA, Bult P, Borm GF, Tjan-Heijnen VC (2010) Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst 102(6):410–425. https://doi.org/10.1093/jnci/djq008

    Article  PubMed  Google Scholar 

  24. Freneaux P, Nos C, Vincent-Salomon A, Genin P, Sigal-Zafrani B, Al Ghuzlan A, Birolini MJ, Clough K, Sastre-Garau X (2002) Histological detection of minimal metastatic involvement in axillary sentinel nodes: a rational basis for a sensitive methodology usable in daily practice. Mod Pathol 15(6):641–646. https://doi.org/10.1038/modpathol.3880580

    Article  PubMed  Google Scholar 

  25. Kadkhodayan S, Hasanzadeh M, Treglia G, Azad A, Yousefi Z, Zarifmahmoudi L, Sadeghi R (2015) Sentinel node biopsy for lymph nodal staging of uterine cervix cancer: a systematic review and meta-analysis of the pertinent literature. Eur J Surg Oncol 41(1):1–20. https://doi.org/10.1016/j.ejso.2014.09.010

    Article  PubMed  CAS  Google Scholar 

  26. Weaver DL, Krag DN, Ashikaga T, Harlow SP, O'Connell M (2000) Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer 88(5):1099–1107

    Article  PubMed  CAS  Google Scholar 

  27. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR (eds) (2017) American Joint Committee on Cancer (AJCC) Staging Manual, 8th edn. Springer International Publishing, New York Dordrecht Heidelberg London

    Google Scholar 

  28. Brierley JD, Gospodarowicz MK, Wittekind C (eds) (2017) TNM classification of malignant tumours, 8th edn. Wiley Blackwell, Oxford

    Google Scholar 

  29. Kalof AN, Cooper K (2006) p16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia. Adv Anat Pathol 13(4):190–194

    Article  PubMed  CAS  Google Scholar 

  30. Carleton C, Hoang L, Sah S, Kiyokawa T, Karamurzin YS, Talia KL, Park KJ, McCluggage (2016) WG a detailed immunohistochemical analysis of a large series of cervical and vaginal gastric-type adenocarcinomas. Am J Surg Pathol 40(5):636–644

    Article  PubMed  PubMed Central  Google Scholar 

  31. Howitt BE, Emori MM, Drapkin R, Gaspar C, Barletta JA, Nucci MR, McCluggage WG, Oliva E, Hirsch MS (2015) GATA3 is a sensitive and specific marker of benign and malignant mesonephric lesions in the lower female genital tract. Am J Surg Pathol 39(10):1411–1409

    Article  PubMed  Google Scholar 

  32. McCluggage WG, Kennedy K, Busam KJ (2010) An immunohistochemical study of cervical neuroendocrine carcinomas: neoplasms that are commonly TTF1 positive and which may express CK20 and P63. Am J Surg Pathol 34(4):525–532

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Professor Elvio Silva for providing Fig. 5 and Mrs. Stephanie Rinner for her help in making part of the gross images.

Author information

Authors and Affiliations

  1. Histopathology and Molecular Diagnostics, University Hospital Careggi, Largo Brambilla, 3, 50134, Florence, Italy

    Maria Rosaria Raspollini

  2. Department of Pathology, Hospital Graz Sued-West and Medical University Graz, Graz, Austria

    Sigurd F. Lax

  3. Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK

    W Glenn McCluggage

Authors
  1. Maria Rosaria Raspollini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sigurd F. Lax
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W Glenn McCluggage
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Rosaria Raspollini.

Ethics declarations

The authors disclose any conflicts of interest with respect to this report. The manuscript does not deal with research involving human participants and/or animals, and therefore, an informed consent was not obtained. No funding was received regarding this report.

Additional information

See related article, doi:10.1007/s00428-018-2362-9.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Raspollini, M.R., Lax, S.F. & McCluggage, W.G. The central role of the pathologist in the management of patients with cervical cancer: ESGO/ESTRO/ESP guidelines. Virchows Arch 473, 45–54 (2018). https://doi.org/10.1007/s00428-018-2372-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-018-2372-7

Keywords

Search

Navigation